期刊文献+

sE-cadherin在实体肿瘤中的表达及临床意义

下载PDF
导出
摘要 本文对SE-cadherin在实体肿瘤中的表达及临床意义进行了综述,结果表明在实体肿瘤中其表达增高,对实体肿瘤的诊断、鉴别诊断、用药监督、疗效观察、愈后判定和制定预防均具有重要价值,值得进一步研究探索。
出处 《内蒙古民族大学学报》 2011年第2期91-92,共2页 Journal of Inner Mongolia University for the Nationalities
基金 内蒙古民族大学自然科学研究项目(MDX2008103) 内蒙古自治区社会发展领域应用技术研究与开发类计划项目(2009年度)
  • 相关文献

参考文献13

  • 1Setsuo H.Inactivation of the E-CD-mediated cell adhesion system in Human cancers[J].Am J Pat hol,1998,153(2):333.
  • 2Nagar B,Overduin M,lkura M.Structural basis of calcium-induced E-cadherin rigidification and dimerization[J].Nature (Land),1996,380:360-364.
  • 3Gofuku J,Sh iozak i H,Dok i Y.Characterization of soluble E-cadherin as a disease marker in gastric cancer patients[J].Br J Cancer,1998,78:1095-1101.
  • 4Chan AO,Chu KM,Lan SK.Serum-soluble E-cadhefin is an independent pretherapeutic factor for long-temsurvival in gastric cancer[J].J C lin Oncol,2003,21(12):2288-2293.
  • 5孙志勇,孙巍,方立俭,秦继宝,汤其岭.肠癌患者手术治疗前后血清VEGF和SE-CAD水平检测的临床意义[J].标记免疫分析与临床,2008,15(4):196-197. 被引量:8
  • 6CioffiM,Gazzerro P,Finizio BD.Serum soluble E-cadherin fragments in lung cancer[J] ).Tumo ri.,1999,85:32-34.
  • 7Naw,rocki Raby B,G illes C,et al.Upregulation of MMPs by soluble E-cadherin in human lung turn or cells[J].Int J Cancer,2003,105(6):790-795.
  • 8Charalabopoulos K,GogaliA,DalavagaY.The clinical significance of soluble E-cadherin in nonsm all cell lung cancer[J].Exp Oncol,2006,28(1):83-85.
  • 9WuW,WalkerA M.Human chorionic gonadotrop in beta (HCGbeta) down-regulates E-cadherin and promnotes human prostate carcinoma cell migration and invasion[J].Cancer,2006,106(1):68-78.
  • 10Griffith s TR,Bmtherick I,Bishop R I.Cell adhesion molecules in bladder cancer:,soluble serum E-cadherin correlates with pred-ictors of recurrence[J].Br J Cancer,1996,74:579-584.

二级参考文献16

  • 1盛世乐,黄钢.VEGF上调survivin和bcl-2表达及抑制乳腺癌细胞凋亡的机制探讨[J].肿瘤,2005,25(6):525-529. 被引量:17
  • 2孙龙安 李龙 林钢 主编.医学特种检验与实验室诊断:第1版[M].北京:人民军医出版社,2001.153.
  • 3GofukuJ, ShiozakiH, Doky, et al. Characterization of soluble E -cadherin as a disease marker in gastric cancer patients. Br J Cancer 1998:78:1095
  • 4Ahmed MI, Abd - Elmotelib F, Farag RH, et al. Evaluation of some tissue and serum biomarkers in prostatic carcinoma among egyptian males.Clin Biochem 1999 ;32:439.
  • 5CioffiM, Gazzerrup, FinizioBD, et al. Serum- soluble E- Cadherin fragments in lung cancer. Tumor 1999;85:32.
  • 6李庆萍 古剑锋.病毒性肝炎血清铁蛋白RIA及临床观察[J].放射免疫学杂志,1991,(1):30-30.
  • 7孙龙安 李龙 等.医学特种检验与实验室诊断(第1版)[M].北京:人民军医出版社,2001.156.
  • 8Poon R T,Fan S T,Wong J. Clinical implications of circulating angiorenic factors in cancer patients [J]. J Clinoneol, 2001,19 (4) : 1207-1210.
  • 9Sato K,Tsuchiya N, Sasaki R,et al. Increased serum levels of vascular endothelial growth factor in patients with renal cell carcinoma[J]. Jpn J Cancer Res, 1999,90(8):874-878.
  • 10Shimanuki Y,Takahashi K,Cui R. et al. Role of serum vascular endothelial growth factor in the prediction of angiogenesis and prognosis for non-small cell lung cancer[J]. Lung, 2005, 183(1) :29-32.

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部